通过实验大鼠肾脏重量预测顺铂诱导肾毒性的模型。
A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats.
作者信息
Nematbakhsh Mehdi, Ashrafi Farzaneh, Nasri Hamid, Talebi Ardeshir, Pezeshki Zahra, Eshraghi Fatemeh, Haghighi Maryam
机构信息
Water and Electrolytes Research Center, Isfahan, Iran ; Department of Physiology, Isfahan, Iran ; Kidney Diseases Research Center, Isfahan, Iran.
出版信息
J Res Med Sci. 2013 May;18(5):370-3.
BACKGROUND
Cisplatin (cis-diamminedichloroplatinum II; CP) is used widely as an antitumor drug in clinics, but is accompanied with renal toxicity. Cisplatin induced nephrotoxicity consists of change in kidney weight, histological changes in kidney and increase in serum creatinine (Cr) and blood urea nitrogen (BUN). This study was designed to find out a model for prediction of cisplatin induced nephrotoxicity.
MATERIALS AND METHODS
Pathological damage score, kidney weight, BUN, and Cr of 227 rats that were involved in different projects were determined. A total of 187 rats were treated with 7 mg/kg cisplatin and sacrificed 1 week later.
RESULTS
There was a good significant correlation between normalized kidney weight and logarithmic scale of BUN and Cr. Relationship between BUN, Cr or normalized kidney weight and pathology damage score was significant.
CONCLUSION
Normalized kidney weight and pathology damage score is a good predictor of renal function in cisplatin induced nephrotoxicity in experimental rats.
背景
顺铂(顺二氨二氯铂II;CP)在临床上被广泛用作抗肿瘤药物,但会伴有肾毒性。顺铂诱导的肾毒性包括肾脏重量变化、肾脏组织学改变以及血清肌酐(Cr)和血尿素氮(BUN)升高。本研究旨在找出一种预测顺铂诱导肾毒性的模型。
材料与方法
测定参与不同项目的227只大鼠的病理损伤评分、肾脏重量、BUN和Cr。共187只大鼠接受7mg/kg顺铂治疗,并在1周后处死。
结果
标准化肾脏重量与BUN和Cr的对数尺度之间存在良好的显著相关性。BUN、Cr或标准化肾脏重量与病理损伤评分之间的关系显著。
结论
标准化肾脏重量和病理损伤评分是实验大鼠顺铂诱导肾毒性中肾功能的良好预测指标。
相似文献
J Renal Inj Prev. 2016-3-25
Int J Prev Med. 2015-7-8
Nephrourol Mon. 2014-9-5
引用本文的文献
Naunyn Schmiedebergs Arch Pharmacol. 2024-9
Int J Nephrol. 2023-7-18
Int J Mol Sci. 2021-1-13
J Pharm Bioallied Sci. 2019-12
本文引用的文献
Saudi J Kidney Dis Transpl. 2012-7
Toxins (Basel). 2010-10-26
Am J Med Sci. 2007-8
Biol Pharm Bull. 2005-9
Semin Nephrol. 2003-9